Bradley Powers
Compliance Officer at LUMOS PHARMA, INC.
Net worth: 14 695 $ as of 2024-06-29
Network origin in Bradley Powers first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bradley Powers via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Atlantic Richfield Co., Inc.
Atlantic Richfield Co., Inc. Integrated OilEnergy Minerals Atlantic Richfield Co. provides oil and gas extraction and production services . The firm's exploration and production operations are focused primarily in the Gulf of Mexico and the midcontinent in the United States, the United Kingdom North Sea, Indonesia, China and Algeria. The company was incorporated on April 15, 1985 and is headquartered in Warrenville, IL. | Integrated Oil | Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
MARRIOTT INTERNATIONAL, INC. | Hotels/Resorts/Cruise lines | Director of Finance/CFO | |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Cycle Solutions, Inc.
Cycle Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Cycle Solutions, Inc. provides contract research services. It also provides project management, site selection, site management, clinical monitoring, regulatory support, online investigators’ meetings, safety monitoring, quality control, online technology collaboration, quality assurance support, medical writing, cardiovascular safety and diagnostic services, protocol consulting design, and biostatistics services. The company was founded by John V. Farinacci in 1999 and is headquartered in Austin, TX. | Miscellaneous Commercial Services | Chief Operating Officer | |
LDR Spine USA, Inc.
LDR Spine USA, Inc. Medical SpecialtiesHealth Technology LDR Spine USA, Inc. offers sterile spinal implant systems. Its product line which includes pre-sterilized fusion devices help in ensuring simple and reliable management of spinal implants. The company was founded in December 1999 and is headquartered in Austin, TX. | Medical Specialties | Director/Board Member Director/Board Member | |
LDR HOLDING CORP | Medical Specialties | Director/Board Member Director/Board Member | |
BioProtection Systems Corp.
BioProtection Systems Corp. BiotechnologyHealth Technology Part of Lumos Pharma, Inc., BioProtection Systems Corp. is a company that manufactures biological products. The company is based in Ames, IA. | Biotechnology | Chairman Director of Finance/CFO | |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
GALERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
SPYRE THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Invisalert Solutions, Inc.
Invisalert Solutions, Inc. Packaged SoftwareTechnology Services Invisalert Solutions, Inc. provides patient safety solutions. The firm offers ObservSMART, a wristband and software-based q15 minute check tracker that replaces pencil and paper-based forms. It specializes in resolving non-compliance issues in the acute healthcare, corrections, drug delivery, long-term care, youth and special education markets. The company was founded by Regina Widdows, Peter Nagy and Michele Marcolongo on August 20, 2014 and is headquartered in Newtown Square, PA. | Packaged Software | Director/Board Member | |
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Mendel Biotechnology, Inc.
Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Texas Tech University | College/University | Undergraduate Degree Undergraduate Degree | |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree | |
University of California San Diego | College/University | Doctorate Degree Doctorate Degree | |
University of Maryland | College/University | Doctorate Degree | |
PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Parke Davis & Co. Ltd.
Parke Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke Davis & Co. Ltd. is a company based in Eastleigh, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Atlantic General Hospital
Atlantic General Hospital Hospital/Nursing ManagementHealth Services Atlantic General Hospital provides healthcare services. The firm offers weight loss services, behavioral health services, cancer care, dermatology services, diabetes outpatient education program, emergency room, endoscopy center, eye surgery center, imaging, radiology and nutrition services. The company was founded on May 21, 1993 and is headquartered in Berlin, MD. | Hospital/Nursing Management | Director/Board Member | |
Roche Diagnostics KK
Roche Diagnostics KK Medical SpecialtiesHealth Technology Part of Roche Holding AG, Roche Diagnostics KK is a Japanese company that manufactures and sells medical equipment. The company is based in Tokyo, Japan. The company was founded in 1932. The CEO is Shin Ogasawara. | Medical Specialties | Corporate Officer/Principal | |
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
Pharmaco
Pharmaco Drugstore ChainsRetail Trade Pharmaco acquires, develops and markets niche pharmaceutical products. The company was founded by Rick J. Hawkins in 1983 and is headquartered in Atlanta, GA. | Drugstore Chains | Chief Executive Officer Corporate Officer/Principal | |
Central Iowa Hospital Corp. | Founder | ||
Rhone-Poulenc Rorer SA | Corporate Officer/Principal | ||
Nexvet Australia Pty Ltd.
Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Director/Board Member | |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Chief Executive Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Stanford University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
Stanford University Center For Biomedical Ethics | Founder | ||
Neuropore Therapies, Inc.
Neuropore Therapies, Inc. Medical/Nursing ServicesHealth Services Neuropore Therapies, Inc. provides biopharmaceutical services. It also offers alpha-synuclein (ASYN), amyloid beta, autophagy, and publications programs. The company was founded by Eliezer Masliah in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member | |
SAVARA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
AKOYA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
NovaScan, Inc.
NovaScan, Inc. Medical SpecialtiesHealth Technology NovaScan, Inc. engages in the development of a technology that electrically images objects. Its technology measures the electrical properties of materials. The firm focuses on breast cancer detection. The company was founded in 2001 by Larry Wells and William Gregory and is headquartered in Chicago, IL. | Medical Specialties | Director/Board Member | |
TrakCel Ltd.
TrakCel Ltd. Packaged SoftwareTechnology Services TrakCel Ltd. delivers a suite of integrated technologies to orchestrate the cell therapy supply chain for autologous and allogeneic therapies. The firm serves to medical centers, distribution and logistics clients, manufacturers, and therapy owners and trial sponsors/license holders. The company was founded in 2012 and is headquartered in Cardiff, the United Kingdom. | Packaged Software | Director/Board Member | |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Pharmaceuticals: Major | Director/Board Member | |
MODALIS THERAPEUTICS CORPORATION | Biotechnology | Director/Board Member | |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Pharmaceuticals: Major | Founder |
Statistics
International
United States | 41 |
Japan | 4 |
United Kingdom | 3 |
Switzerland | 2 |
Ireland | 2 |
Sectoral
Health Technology | 27 |
Consumer Services | 7 |
Commercial Services | 5 |
Health Services | 4 |
Technology Services | 3 |
Operational
Director/Board Member | 104 |
Corporate Officer/Principal | 38 |
Independent Dir/Board Member | 36 |
Founder | 25 |
Chief Tech/Sci/R&D Officer | 25 |
Most connected contacts
Insiders | |
---|---|
Emmett Cunningham | 29 |
Kevin Lalande | 24 |
Richard Hawkins | 21 |
Lota Zoth | 20 |
Joseph McCracken | 20 |
Thomas Raffin | 19 |
An van Es-Johansson | 13 |
David Karpf | 11 |
John McKew | 11 |
Charles Link | 10 |
Aaron Schuchart | 10 |
Carl W. Langren | 10 |
Eugene Kennedy | 9 |
Robert J. Davis | 8 |
Chad Johnson | 6 |
- Stock Market
- Insiders
- Bradley Powers
- Company connections